Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

Elizabeth J. Ziegler; Charles J. Fisher; Charles L. Sprung; Richard C. Straube; Jerald C. Sadoff; Garrett E. Foulke; Cornelis H. Wortel; Mitchell P. Fink; R. Phillip Dellinger; Nelson N.H. Teng; I. Elaine Allen; Harvey J. Berger; Genell L. Knatterud; Albert F. LoBuglio; Craig R. Smith; I. Elaine Allen; Harvey J. Berger; Genell L. Knatterud; Albert F. LoBuglio; Craig R. Smith

New England Journal of Medicine (1991) - Comment
pubmed: 1988827 doi: 10.1056/nejm199102143240701 issn: 0028-4793 issn: 1533-4406

Elizabeth J. Ziegler, Charles J. Fisher, Charles L. Sprung, Richard C. Straube, Jerald C. Sadoff, Garrett E. Foulke, Cornelis H. Wortel, Mitchell P. Fink, R. Phillip Dellinger, Nelson N.H. Teng, I. Elaine Allen, Harvey J. Berger, Genell L. Knatterud, Albert F. LoBuglio, Craig R. Smith, I. Elaine Allen, Harvey J. Berger, Genell L. Knatterud, Albert F. LoBuglio, Craig R. Smith

Go to article
Go to preprint

Massachusetts Medical Society